Organigram Global (OGI) Other Non Operating Income (2018 - 2026)
Organigram Global (OGI) posted quarterly Other Non Operating Income of $1.4 million for Q1 2026, up 1187.12% year-on-year from $108719.0 in Q1 2025, and up 49.99% on a QoQ basis from $932929.3 in Q4 2025.
Organigram Global (OGI) Other Non Operating Income (2018 - 2026) Analysis & Trends
Organigram Global (OGI) has reported Other Non Operating Income for 7 consecutive years, with $1.4 million the latest figure, recorded in Q1 2026.
- Quarterly Other Non Operating Income rose 1187.12% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $996410.4 (down 99.54% YoY) and the FY2025 annual result came in at $2.5 million, changed N/A from the prior year.
- Other Non Operating Income climbed to $1.4 million in Q1 2026 per OGI's latest filing, from $932929.3 in the prior quarter.
- Over the last five years, Other Non Operating Income for OGI reached as high as $1.4 million in Q1 2026 and fell as low as -$1.4 million in Q4 2024.
- A 3-year average of $249102.6 and a median of $520824.1 in 2025 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2025 — Other Non Operating Income soared 164.58% — and 2026, when it jumped 1187.12%.
- Year by year, Other Non Operating Income stood at -$1.4 million in 2024, then surged by 164.58% to $932929.3 in 2025, then surged by 49.99% to $1.4 million in 2026.
- According to Business Quant data, Other Non Operating Income over the past three periods registered $1.4 million, $932929.3, and $108719.0 for Q1 2026, Q4 2025, and Q1 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Organigram Global | 89.89 Mn | 122.96 Mn | 28.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.40 Mn |
| Dec 31, 2025 | 932,929.25 |
| Mar 31, 2025 | 108,718.97 |
| Dec 31, 2024 | -1.44 Mn |
| May 31, 2021 | 220.04 Mn |
| Feb 28, 2021 | 66,000.00 |
| Nov 30, 2020 | 4.67 Mn |
| May 31, 2020 | 160,896.91 |
| Feb 29, 2020 | 33,000.00 |
| May 31, 2019 | -17,173.49 |
| Feb 28, 2019 | 54,000.00 |
| Nov 30, 2018 | 972,000.00 |
| Aug 31, 2018 | 1.17 Mn |
| May 31, 2018 | 1.16 Mn |